Disclosed herein is at least one cyclopropyl amide derivative, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative disclosed herein, and at least one method of using at least one cyclopropyl amide derivative disclosed herein for treating at least one histamine H3 receptor associated condition therewith.

 
Web www.patentalert.com

< HSP90 INHIBITORS CONTAINING A ZINC BINDING MOIETY

> TARTRATE SALTS OF QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY

> VEGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY
~ 00506